title: Physiologic evidence for high-frequency chest wall oscillation and positive expiratory pressure breathing in hospitalized subjects with cystic fibrosis.
abstract: OBJECTIVE
  This investigation identified ventilation distribution, gas mixing, lung function, and arterial blood oxyhemoglobin saturation (SpO2) physiologic responses to 2 independent airway clearance treatments, high-frequency chest wall oscillation (HFCWO) and low positive expiratory pressure (PEP) breathing, for subjects who had cystic fibrosis (CF) and who were hospitalized during acute and subacute phases of a pulmonary exacerbation.
  
  
  METHODS
  Fifteen subjects with moderate to severe CF were included in this study.
  
  
  METHODS
  Subjects performed single-breath inert gas tests and spirometry before and immediately after HFCWO and PEP breathing at admission and discharge. Arterial blood oxyhemoglobin saturation was monitored throughout each treatment.
  
  
  RESULTS
  At admission and discharge, PEP breathing increased SpO2 during treatment, whereas HFCWO decreased SpO2 during treatment. Ventilation distribution, gas mixing, and lung function improved after HFCWO or PEP breathing.
  
  
  CONCLUSIONS
  High-frequency chest wall oscillation and PEP breathing are similarly efficacious in improving ventilation distribution, gas mixing, and pulmonary function in hospitalized people with CF. Because SpO2 decreases during HFCWO, people who have moderate to severe CF and who use HFCWO should have SpO2 monitored during an acute exacerbation.
authors.affiliation: Department of Rehabilitation Sciences, Division of Physical Therapy, College of Health Sciences, University of Kentucky, 900 S Limestone St, Lexington, KY 40536, USA. darbee@uky.edu
authors.forename: Joan C
authors.initials: JC
authors.lastname: Darbee
authors.forename: Jamshed F
authors.initials: JF
authors.lastname: Kanga
authors.forename: Patricia J
authors.initials: PJ
authors.lastname: Ohtake
mesh_terms: D000293:Adolescent; D001784:Blood Gas Analysis; D035641:Chest Wall Oscillation; D003550:Cystic Fibrosis / Q000628:therapy*; D005260:Female; D006760:Hospitalization; D006801:Humans; D008176:Lung Volume Measurements; D008297:Male; D011175:Positive-Pressure Respiration